Dual enhancement of triple immunofluorescence using two antibodies from the same species

https://doi.org/10.1016/j.jneumeth.2003.12.003Get rights and content

Abstract

Triple immunofluorescence method with two mouse monoclonal antibodies and another rabbit polyclonal antibody was established with catalyzed reporter deposition (CARD) amplification on thick floating sections from the rat cerebellum. One of the monoclonal antibodies (anti-calbindin), diluted maximally, probed with anti-mouse IgG–horseradish peroxidase (HRP) and amplified with Cy5-conjugated tyramide, immunolabeled cerebellar Purkinje cells and their arborization. Subsequently, a rabbit polyclonal IgG (anti-glial fibrillary acidic protein (anti-GFAP)), probed with anti-rabbit IgG–HRP, amplified with biotin–tyramide and visualized with fluorescein-isothiocyanate (FITC)–streptavidin, immunolabeled Bergmann’s glia. Another mouse monoclonal IgG (anti-SNAP25), probed with anti-mouse IgG–rhodamine without CARD amplification, selectively visualized synaptic sites, because the maximal dilution of the other monoclonal antibody (anti-calbindin) was below the detection threshold of this anti-mouse IgG–rhodamine. Separation of the two signals (calbindin and SNAP25), each detected through mouse monoclonal antibody, was then based on the difference of sensitivity either with or without CARD amplification. Triple immunofluorescence is possible when just one of the three primary antibodies is from different species. Intensification of two of the three signals provides further advantages to examine immunolocalization of multiple epitopes on histological sections.

Introduction

Multifluorolabeling immunohistochemistry is an indispensable tool to examine spatial relationship between epitopes on histological sections. It requires a clear separation of signals and sufficient intensity of each signal. Because the signals obtained with conventional fluorochromes conjugated with secondary antibodies are not always intense enough, several signal amplification methods have been developed. Among them, catalyzed reporter deposition (CARD) method is now frequently used as one of the methods of choice (Adams, 1992, Bobrow et al., 1989). Amplification with CARD method is mediated by horseradish peroxidase (HRP), usually conjugated with secondary antibodies and reacted with tyramide in the presence of hydrogen peroxide. This yields amplified signal represented by a reporter molecule, such as biotin or fluorochrome, conjugated in advance with tyramide, that accumulates around HRP (Adams, 1992, Bobrow et al., 1989). Signal amplification with CARD method allows further dilution of the primary antibody below the threshold detectable with non-amplified conventional method using fluorochrome-labeled secondary antibodies (Kumar et al., 1999, Speel et al., 1997, van Gijlswijk et al., 1997). Hunyaday et al. (1996) first reported that a combination of this highly sensitive method with conventional fluorolabeling enabled double immunolabeling based on this difference in the detection threshold even when the two epitopes were probed with primary antibodies of the same class from the same species. This double labeling with antibodies from the same species can be combined with an additional antibody from another species without danger of cross-reaction, as we demonstrated recently (Uchihara et al., 2003). Moreover, by using tyramide-conjugated fluorochromes, it is possible to amplify two immunofluorescent signals from two antibodies from different species (Uchihara et al., 2000). Because this dual amplification allows further dilution of these two primary antibodies, it can be theoretically combined with an additional primary antibody (the third antibody) from either species. A fluorochorome-labeled secondary antibody that visualizes the third antibody is not sensitive enough to immunolabel the diluted primary antibodies that have been already visualized. Triple labeling achieved in this way, therefore, involves two antibodies from the same species, one of which should be amplified, and another antibody from different species, that can also be amplified. In this study, we used, as primary antibodies, two mouse monoclonal IgGs and a rabbit polyclonal IgG to perform triple labeling. Amplification of the signal from the rabbit polyclonal IgG and another from one of the two mouse monoclonal IgGs yielded signals intense enough to be detected in the thick sections.

Section snippets

Materials and methods

Wistar rats at postnatal day 14 (P14) were perfused transcardially with Zamboni fixative under anesthesia with inhaled diethyl ether followed by intraperitoneal administration of pentobarbital (60 mg/kg). The cerebella were taken immediately and further immersed in the same fixative overnight. After being rinsed in phosphate-buffered saline (PBS), the fixed tissues were cryoprotected by immersion in 20% sucrose in 0.1 M phosphate buffer. Floating sections with a thickness of 30 μm were obtained on

Results

Fig. 1 shows the triple-fluorolabeled images of the rat cerebellum at P14. Although two (calbindin: C, blue; SNAP25: B, red) of the three epitopes were probed with anti-mouse IgG of the same class, there was practically no overlap between the fluorescent signals. Each signal was captured independently and emission peak of each, measured with spectrophotometer (Leica TCS/SP), was not different from that expected from each fluorochrome used, as shown in Table 1. This confirmed that the detection

Discussion

We successfully performed triple immunofluorescence with two antibodies of mouse monoclonal IgG and another antibody of rabbit polyclonal IgG. Amplifying one (calbindin) of the two signals with the CARD method enabled to dilute this antibody (anti-calbindin, usually more than another 10-fold) below the threshold (Uchihara et al., 2000, Uchihara et al., 2003) that is detectable directly with the conventional secondary anti-mouse IgG conjugated with rhodamine red. This enabled to distinguish two

Acknowledgements

Supported in part by the grants (TU) from the Ministry of Health, Labor and Welfare (Longevity Science H-14-005) and from the Ministry of Education, Culture, Sports, Science and Technology (grant-in-aid for Scientific Research B15300118).

References (9)

  • M.N. Bobrow et al.

    Catalyzed reporter deposition, a novel method of signal amplification. Application to immunoassays

    J. Immunol. Methods

    (1989)
  • J.C. Adams

    Biotin amplification of biotin and horseradish peroxidase signals in histochemical stains

    J. Histochem. Cytochem.

    (1992)
  • B. Hunyaday et al.

    Immunohistochemical signal amplification by catalyzed reporter deposition and its amplification in double immunostaining

    J. Histochem. Cytochem.

    (1996)
  • R.K. Kumar et al.

    Improved double immunofluorescence for confocal laser scanning microscopy

    J. Histochem. Cytochem.

    (1999)
There are more references available in the full text version of this article.

Cited by (12)

  • Troubleshooting tissue specificity and antibody selection: Procedures in immunohistochemical studies

    2010, Journal of Pharmacological and Toxicological Methods
    Citation Excerpt :

    Our concern focused on the careful controls necessary with triple labeling of the MCA using two monoclonal antibodies from mouse (anti-eNOS IgG1 and nNOS IgG2a) and one from rabbit polyclonal antibody (anti-GFAP). Reports listing triple immunofluorescence using two antibodies from the same species indicate the use of highly sensitive tyramide signal amplification systems for triple staining (Nakamura & Uchihara, 2004; Toth & Mezey, 2007; Brouns et al., 2002). Although the tyramide signal amplification has been successful to test polyclonal antibodies, the technique still requires the sequential addition of antibodies.

  • Dendritic A-type potassium channel subunit expression in CA1 hippocampal interneurons

    2008, Neuroscience
    Citation Excerpt :

    Sections were incubated in species- or isotype-specific Alexa-conjugated secondary antibodies (Molecular Probes-Invitrogen, Carlsbad, CA, USA) as described elsewhere (Strassle et al., 2005). For the double labeling of Kv4.3 and axons in Fig. 2A, we used the tyramide signal amplification (TSA) method to achieve immunolabeling with two antibodies from the same species (Teramoto et al., 1998; Nakamura and Uchihara, 2004). Sections were first incubated overnight with 50 ng/ml of K75/41 at which concentration this monoclonal antibody is not detected by Alexa-conjugated secondary antibodies (not shown).

  • Heterogeneity of glutamatergic and GABAergic release machinery in cerebral cortex

    2007, Neuroscience
    Citation Excerpt :

    To determine the optimum VGLUT2 or SYNII concentration for TSA, serial dilutions were tested with and without TSA until an optimal dilution was found (1:50,000 for VGLUT2; 1:1000 for SYNII) that yielded VGLUT2 or SYNII immunofluorescence only with amplification. Sections were then processed using the TSA fluorescent system (NEL701; Perkin-Elmer Life Sciences, Boston, MA, USA) as described (Nakamura and Uchihara, 2004; Vruwink et al., 2001). After amplification of the primary antibody to VGLUT2 or SYNII, visualization of the second antibody (either SYPI, SYPII or SNAP-23) was performed as described above.

View all citing articles on Scopus
View full text